Association between the modified Japanese Version of High Bleeding Risk scores and clinical outcomes in Japanese patients with lower extremity artery disease undergoing endovascular treatment
Heart Vessels. 2025 Nov 23.
doi: 10.1007/s00380-025-02629-0.
Online ahead of print.
1 Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City, Kagoshima, 890-8520, Japan. shimono.hirokazu@beige.plala.or.jp.
2 Department of Cardiovascular Medicine and Hypertension, Graduate School of Medical and Dental Sciences, Kagoshima University, 8-35-1 Sakuragaoka, Kagoshima City, Kagoshima, 890-8520, Japan.
3 Department of Prevention and Analysis of Cardiovascular Diseases, Graduate School of Medical and Dental Sciences, Kagoshima University, Kagoshima, Japan.
4 Department of Clinical Pharmacology and Therapeutics, University of the Ryukyus School of Medicine, Okinawa, Japan.
Keywords:
Academic Research Consortium for High Bleeding Risk (ARC-HBR); Endovascular treatment (EVT); High bleeding risk; Lower extremity artery disease (LEAD); Modified Japanese Version of High Bleeding Risk (J-HBR).